"
Chemosensitivity Testing of Circulating Epithelial Tumor Cells (CETC) in Vitro: Correlation to in Vivo Sensitivity and Clinical Outcome"
written by Nadine Rudiger, Ernst-Ludwig Stein, Erika Schill, Gabriele Spitz, Carola Rabenstein, Martina Stauch, Matthias Rengsberger, Ingo B. Runnebaum, Ulrich Pachmann, Katharina Pachmann,
published by
Journal of Cancer Therapy,
Vol.4 No.2, 2013
has been cited by the following article(s):
[1]
|
Circulating Tumour Cells in Predictive Molecular Pathology: Focus on Drug-Sensitive Assays and 3D Culture
|
|
2019 |
|
|
[2]
|
Stoffwechselmerkmale der Tumorzellen als Ziel komplementärer Therapien
|
|
2018 |
|
|
[3]
|
Stoffwechselmerkmale der Tumorzellen als Ziel komplementärer Therapien Metabolic Hallmarks of Tumor Cells as Target for Complementary Therapies
|
|
Deutsche Zeitschrift für Onkologie,
2018 |
|
|
[4]
|
Circulating epithelial tumor cells as a prognostic tool for malignant melanoma
|
|
Melanoma Research,
2018 |
|
|
[5]
|
Zirkulierende epitheliale Tumorzellen in der Krebsdiagnostik
|
|
2016 |
|
|
[6]
|
Treatment of advanced solid tumours with NSAIDs: Correlation of quantitative monitoring of circulating tumour cells and positron emission tomography-computed …
|
|
2016 |
|
|
[7]
|
Treatment of advanced solid tumours with NSAIDs: Correlation of quantitative monitoring of circulating tumour cells and positron emission tomography …
|
|
2016 |
|
|
[8]
|
Treatment of advanced solid tumours with NSAIDs: Correlation of quantitative monitoring of circulating tumour cells and positron emission tomography‑computed …
|
|
2016 |
|
|
[9]
|
Treatment of advanced solid tumours with NSAIDs: Correlation of quantitative monitoring of circulating tumour cells and positron emission tomography- …
|
|
2016 |
|
|
[10]
|
May CTC technologies promote better cancer management?
|
|
EPMA Journal,
2015 |
|
|
[11]
|
Current and potential use of MAINTRAC method for cancer diagnosis and prediction of metastasis
|
|
Expert review of molecular diagnostics,
2015 |
|
|
[12]
|
Erfolgreiche Optimierung einer Chemotherapie mittels Chemosensitivit?tsprüfung an zirkulierenden Tumorzellen
|
|
C Weigl, C Rabenstein, U Pachmann, K Pachmann - maintrac.com,
2014 |
|
|
[13]
|
Erstmaliger Nachweis einer Vitalitätsreduktion von Tumorstammzellen aus dem Blut eines Patienten mit Prostatacarcinom durch eine Polyphenolmischung
|
|
Informationen zum Maintrac-Verfahren 4/6,
2013 |
|
|
[14]
|
Kompetenznetz Chronische Venen-krankheiten UG–haftungsbeschränkt–, SIMFO GmbH, Laborpraxis Dr. med. U. Pachmann Klinischer Test für …
|
|
|
|
|
[1]
|
Circulating Tumour Cells in Predictive Molecular Pathology: Focus on Drug-Sensitive Assays and 3D Culture
Acta Cytologica,
2019
DOI:10.1159/000496213
|
|
|
[2]
|
Circulating Tumour Cells in Predictive Molecular Pathology: Focus on Drug-Sensitive Assays and 3D Culture
Acta Cytologica,
2019
DOI:10.1159/000496213
|
|
|
[3]
|
Circulating epithelial tumor cells as a prognostic tool for malignant melanoma
Melanoma Research,
2018
DOI:10.1097/CMR.0000000000000407
|
|
|
[4]
|
Circulating epithelial tumor cells as a prognostic tool for malignant melanoma
Melanoma Research,
2018
DOI:10.1097/CMR.0000000000000407
|
|
|
[5]
|
Treatment of advanced solid tumours with NSAIDs: Correlation of quantitative monitoring of circulating tumour cells and positron emission tomography-computed tomography imaging
Oncology Letters,
2016
DOI:10.3892/ol.2016.4878
|
|
|
[6]
|
May CTC technologies promote better cancer management?
EPMA Journal,
2015
DOI:10.1186/s13167-014-0023-x
|
|
|
[7]
|
Current and potential use of MAINTRAC method for cancer diagnosis and prediction of metastasis
Expert Review of Molecular Diagnostics,
2015
DOI:10.1586/14737159.2015.1032260
|
|
|